Stomach Cancer Trial, Recruiting NCT05010863 Sponsor: Second Affiliated Hospital of Wenzhou Medical University Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT05010863
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with cancer:

  • Adults aged 18 or older
  • People who have been diagnosed with cancer confirmed by a laboratory tissue test (pathology)
  • People who are able to provide enough tissue samples for testing
  • People who have not yet received any cancer treatment
  • People who are willing to give written consent to take part

For healthy volunteers:

  • Adults aged 18 or older
  • People who have no known underlying health conditions
  • People who are able to provide enough tissue samples for testing
  • People who are willing to give written consent to take part

Who may not be able to join:

  • People whose cancer cannot be clearly identified as coming from a specific tumour type
  • People who have a history of other tumours, autoimmune diseases, or allergies
  • People who have previously had cancer treatments such as surgery, chemotherapy, radiation, targeted therapy, immunotherapy, biological therapy, or certain traditional Chinese medicines listed as having anti-cancer effects
  • People who have taken part in any other clinical trial within the 90 days before this study
  • People who have had major surgery within the 90 days before this study
  • People who received a bone marrow transplant within the 90 days before this study
  • People who the trial investigators determine may be unable to complete the study for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13857772361

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Registry
ClinicalTrials.gov
Start date
1 January 2021
Est. completion
30 December 2023

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Getting serum

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov